DUBLIN, Ireland - (Business Wire) Research and Markets (
http://www.researchandmarkets.com/research/8f20c2/china_pharmaceutic) has announced the addition of the "China Pharmaceutical Chain Industry Report, 2007-2008" report to their offering.
The pharmaceutical industry is called the "eternal sunrise industry", mainly because of its sustained growth in market demand. The main factors driving this growth include economic growth, improved public awareness of healthcare, the aging population, urbanization and health system reform, which has greatly promoted the ability and willingness of medical consumption. According to the forecasts of IMS, China will become the seventh largest pharmaceutical market in the world in 2009 and will jump to the second largest one with a market capacity of US$220 billion after the U.S.A. in 2020.
According to the latest statistics of the National Bureau of Statistics, the sales revenue of China's pharmaceutical industry in the first five months of this year reached CNY271.78 billion, up 26.63% year on year. In 2007, sales revenue reached CNY575.4 billion, rising 21.5% year on year. The average growth rate of sales revenue of China's pharmaceutical industry in the past ten years exceeded 20%, far higher than GDP growth rate in the same period. Moreover, the profit growth rate of China's pharmaceutical industry in the past two years was much higher than the growth rate of sales revenues. The total profit of China's pharmaceutical industry in the first eleven months of 2007 reached CNY49.9 billion, jumping 51% year on year. In 2008, the industry continued maintaining the momentum of fast growth, and the total profit of the industry in the first five months of this year stood at CNY26 billion, 41.4% year on year, which is mainly attributed to government support and industry restructuring.
Due to the impact of many factors, including a price competition and market disorder, China's pharmaceutical chain industry was in trouble in the past four years. However, the industry had a turn for the better in 2007 after experiencing industry restructuring and gradually improved corporate operations in 2006. In 2007, net profit rate of China Top 100 pharmaceutical chain companies reached about 3%, higher than that in the previous year, and the growth rate of profit reached 56.2%, far higher than the growth rate of sales revenue.
Although we are optimistic about our forecast of potential market development, rapid expansion of pharmaceutical chain industry in large cities like Beijing, Shanghai, Guangzhou and Shenzhen has saturated the market in these large cities. Rising cost, price competition, new medical reform and other factors have made it increasingly difficult for medium- and small-sized drugstores to survive. It is increasingly clear that China should further restructure its pharmaceutical chain industry to raise industrial concentration degree, which is also a good opportunity for powerful companies to further strengthen their presence in the industry.
This report is based on the authoritative statistics of the National Bureau of Statistics, the Ministry of Health, the State Food and Drug Administration, the China Association of Pharmaceutical Commerce and the China Drugstore website, as well as information from annual financial reports and the websites of some key companies.
| Key Topics Covered: |
| |
| 1. Overview of China Pharmaceutical Chain Industry |
| 2. Operating Status of China Pharmaceutical Industry |
| 3. Operating Status of China Pharmaceutical Chain Industry |
| 4. Competition Status of China Pharmaceutical Chain Industry |
| 5. Key Regions of China Pharmaceutical Chain Industry |
| 6. Development Trend of China Pharmaceutical Chain Industry |
| 7. Key Companies of China Pharmaceutical Chain Industry |
| |
| Companies Mentioned: |
| |
| - Laobaixing Drugstore |
| - Nepstar Drugstore |
| - Hubei Tongjitang Drugstore |
| - Chongqing Tongjunge Drugstore |
| - Guoda Drugstore of Sinopharm Medicine Holding Co. |
| - Liaoning Chengda Fangyuan Chain Drugstore |
| - Chongqing Heping Drugstore |
| - Jiangxi Kaixinren Drugstore |
| - Guangdong Dashenlin Drugstore |
| - Yunnan Hongxiang Pharmaceutical Co.(Yixintang Drugstore) |
| - Shanghai Huashi Drugstore |
| - Hunan Zhilin Drugstore |
| - Shenzhen Zhonglian Drugstore |
| - Shenyang Northeast Drugstore |
| - Beijing Jinxiang Drugstore |
| - Tongrentang Drugstore |
| - Guizhou Yishu Drugstore |
| - Medicine Shoppe |
For more information visit http://www.researchandmarkets.com/research/8f20c2/china_pharmaceutic.
Research and Markets
Laura Wood
Senior Manager
press@researchandmarkets.com
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
